We are live on
!
Find out more
NMC
NEA Management Company Portfolio holdings
AUM
$1.76B
1-Year Est. Return
223.33%
This Fund
S&P 500
This Quarter
Est. Return
+1.82%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$1.3B
AUM Growth
-$473M
(-27%)
Cap. Flow
-$455M
Cap. Flow
% of AUM
-35.08%
Top 10 Holdings %
Top 10 Hldgs %
80.36%
Holding
41
New
–
Increased
2
Reduced
3
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Senti Biosciences Holdings
SNTI
|
+$13M |
| 2 |
Oric Pharmaceuticals
ORIC
|
+$5.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VRNA
Verona Pharma
VRNA
|
+$173M |
| 2 |
TEM
Tempus AI
TEM
|
+$150M |
| 3 |
NextNav
NN
|
+$127M |
| 4 |
Geron
GERN
|
+$9.83M |
| 5 |
Sagimet Biosciences
SGMT
|
+$9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 92.44% |
| 2 | Consumer Staples | 6.6% |
| 3 | Industrials | 0.55% |
| 4 | Communication Services | 0.41% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACLX
1
DELISTED
Arcellx
ACLX
| $246M | 18.92% |
3,745,262
| – | – |
|
|
VRNA
2
DELISTED
Verona Pharma
VRNA
| $171M | 13.15% |
2,688,565
-2,896,188
| -52% | -$173M |
|
3
Rhythm Pharmaceuticals
RYTM
$7.31B
| $154M | 11.87% |
2,909,956
| – | – |
|
|
TEM
4
Tempus AI
TEM
$7.48B
| $126M | 9.72% |
2,615,979
-2,770,000
| -51% | -$150M |
|
5
Coursera
COUR
$1.77B
| $85.7M | 6.6% |
12,867,769
| – | – |
|
6
Trevi Therapeutics
TRVI
$2.57B
| $71.5M | 5.51% |
11,370,376
| – | – |
|
7
Savara
SVRA
$1.08B
| $67.8M | 5.22% |
24,471,264
| – | – |
|
8
CRISPR Therapeutics
CRSP
$4.69B
| $54M | 4.16% |
1,587,854
| – | – |
|
9
Monte Rosa Therapeutics
GLUE
$1.82B
| $35.7M | 2.75% |
7,692,298
| – | – |
|
10
Aurinia Pharmaceuticals
AUPH
$1.95B
| $31.9M | 2.46% |
3,969,834
| – | – |
|
|
MBX
11
MBX Biosciences
MBX
$3.04B
| $26.7M | 2.05% |
3,614,486
| – | – |
|
12
CVRx
CVRX
$131M
| $24.8M | 1.91% |
2,026,083
| – | – |
|
|
ZBIO
13
Zenas BioPharma
ZBIO
$1.96B
| $20.7M | 1.59% |
2,613,948
| – | – |
|
14
Gossamer Bio
GOSS
$101M
| $19.9M | 1.53% |
18,093,034
| – | – |
|
15
Korro Bio
KRRO
$145M
| $19M | 1.46% |
1,090,793
| – | – |
|
|
NEUE
16
DELISTED
NeueHealth
NEUE
| $18.4M | 1.42% |
2,726,917
| – | – |
|
17
Champions Oncology
CSBR
$75.9M
| $14.9M | 1.15% |
1,713,720
| – | – |
|
|
18
Senti Biosciences Holdings
SNTI
$10.8M
| $12.7M | 0.98% |
3,775,615
+3,333,000
| +753% | +$13M |
|
19
Celcuity
CELC
$4.06B
| $12.6M | 0.97% |
1,250,001
| – | – |
|
20
Phathom Pharmaceuticals
PHAT
$928M
| $12.3M | 0.95% |
1,960,169
| – | – |
|
|
21
Oric Pharmaceuticals
ORIC
$1.17B
| $12.3M | 0.94% |
2,195,545
+629,464
| +40% | +$5.5M |
|
|
RGLS
22
DELISTED
Regulus Therapeutics
RGLS
| $11.3M | 0.87% |
6,467,802
| – | – |
|
|
DM
23
DELISTED
Desktop Metal, Inc.
DM
| $7.07M | 0.54% |
1,439,892
| – | – |
|
24
Black Diamond Therapeutics
BDTX
$95.1M
| $6.9M | 0.53% |
4,448,757
| – | – |
|
25
Nkarta
NKTX
$152M
| $6.57M | 0.51% |
3,568,781
| – | – |
|
Similar funds
NM
SLF
CCIA
SW
CGH
PWP
CIP
KOCAA
NEA Management Company's Q1 2025 Portfolio in Review
As of Q1 2025, NEA Management Company held 41 positions worth $1.3B, down 27% from $1.77B the previous quarter. Its ten largest holdings account for 80% of the portfolio.
NEA Management Company withdrew a net $455M in Q1 2025, closing 4 positions and reducing 3 holdings. Its most notable exit was NextNav, an estimated $127M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 86% a quarter earlier, followed by Consumer Staples and Industrials.
Against the trend, NEA Management Company added an estimated $13M to Senti Biosciences Holdings.
- NEA Management Company added most to Senti Biosciences Holdings in Q1 2025, an estimated $13M increase.
- NEA Management Company's biggest Q1 2025 reduction was Verona Pharma, cutting an estimated $173M.
- NEA Management Company fully exited NextNav in Q1 2025, selling an estimated $127M.
- NEA Management Company's ten largest holdings make up 80% of its $1.3B portfolio in Q1 2025.
- NEA Management Company opened 0 new positions and closed 4 in Q1 2025.
- NEA Management Company's portfolio value fell 27% quarter-over-quarter to $1.3B.
Based on NEA Management Company's 13F filing for Q1 2025, filed 14 May 2025.